New search | Conferencedetail
mail
Print view
 
 

2nd CRISPR-Based Therapy Analytical Development Summit

Evvnt Promotion / evvnt
-
17.09.2024 - 19.09.2024  Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 9:00 AM - 5:00 PM
 
Conference themes
As CRISPR-based therapies become ever complex, drug developers urgently need to innovate the analytical tools available to effectively characterize their safety and efficacy profiles and agree upon gold standards moving forward. We are also witnessing increased regulatory scrutiny, with the FDA closely studying off-target analysis conducted ahead of the approval of Casgevy, prior to finalizing guidance on genome editing therapies in January.
Professional congress organizer (PCO)
Hanson Wade
Notes
URL:
Brochure: https://go.evvnt.com/2433843-3?pid=4832

Speakers: Andrew Kernytsky, Principal Consultant, Next Gen Editing, Bryant Chia, Scientist, Analytical Chemistry and Structural Biology, Editas Medicine, and more
 

Enquiries and Registration:

https://go.evvnt.com/2433843-2?pid=4832
Ms. Jasmine Fletcher
 
Categories
General Medicine
Languages
English
Congress fees
USD 2599.00 - USD 5796.00
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Ärztekammer für WiennewTreeEuropean Health Forum GasteinAlumni Club Medizinische Universität WienHelix - Forschung & Beratung WienÖsterreichisches Rotes KreuzEuropean Public Health Association (EUPHA)Österreichische Akademie der Ärzte